Navigation Links
Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
Date:12/8/2012

a treatment associated with both short- and long-term toxicities.

ALL, the most common form of leukemia in children, is a fast-growing cancer of the white blood cells in which the bone marrow makes a large number of abnormal white blood cells that are unable to develop and fight infection. Important developments over the past 20 years have led to seminal insights about ALL in children, and today nearly 90 percent of children diagnosed with standard-risk ALL are cured. Some treatment regimens for standard-risk ALL include initial infusions of daunorubicin, a type of anthracycline. While effective, continual use of this therapy is associated with potential long-term heart damage, leading researchers to assess whether eliminating or reducing the dosage of daunorubicin during the initial one-month induction therapy period might provide the same level of efficacy as the standard treatment protocol with reduced long-term risk.

In order to assess the efficacy of ALL treatment without daunorubicin during induction therapy, a team of researchers from 20 centers across France and one center in Belgium initiated a multicenter Phase III clinical trial in which 1,128 pediatric patients with standard-risk B-cell ALL were randomized into two treatment arms. Arm A included 560 patients who received a standard dose of daunorubicin during induction therapy, while Arm B included 568 patients who did not receive initial therapy with daunorubicin. Both groups received doxorubicin during delayed intensification (last treatment phase before reaching maintenance) and a standard protocol of 24-month maintenance therapy from December 2000 to June 2010, during which five-year event-free survival (EFS) and overall survival (OS) were assessed.

For those patients treated with daunorubicin, the five-year EFS rate was 92.9 percent, compared to 93.3 percent in the non-daunorubicin arm. Overall survival rates were 97.2 percent and 98.2 percent in the daunorubicin and n
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
2. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
3. Sharp spike in computer-related injuries predicted for medical workers, find studies
4. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
5. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
6. New studies show effects of mammography guideline changes
7. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
8. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
9. Cancer Drug Reduced Relapses in MS Patients: Studies
10. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
11. Studies Show Limits, Promise of Laser Removal of Tattoos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 2015 , ... Zejax is a New Way of Training ... , World renown body weight trainer, Paul Ziachik, announces today that he ... a person’s training capability. , The American College of Sports Medicine states that ...
(Date:7/30/2015)... ... July 30, 2015 , ... Glidewell Laboratories, industry-leading provider ... Inclusive™ magazine, its multimedia publication focused on implant dentistry, is now available in ... Volume 6, Issue 2, as well as past issues of the dental laboratory’s ...
(Date:7/30/2015)... ... 2015 , ... Western University of Health Sciences faculty, students and alumni were ... largest sports and humanitarian event in the world this year and the single biggest ... July 25 through August 2, 2015, benefited from the participation of WesternU’s colleges of ...
(Date:7/30/2015)... ... July 30, 2015 , ... On July 23rd ... in taxpayer money to fund the state’s large prison system, which has amassed largely ... highest rates of incarceration. In light of President Obama’s recent reduction of non violent ...
(Date:7/30/2015)... ... July 30, 2015 , ... Quintessa Medical Spa is ... a nonsurgical treatment designed specifically for the elimination of excess tissue under ... first locations in the state of Wisconsin to offer this innovative treatment. , Developed ...
Breaking Medicine News(10 mins):Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 4Health News:WesternU Makes Big Impact at Special Olympics 2Health News:WesternU Makes Big Impact at Special Olympics 3Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2
... $14 million from the Centers for Disease Control and ... fight HIV/AIDS in eight countries that lack the large-scale ... $8 million of the grant will support the efforts ... of Health of Ethiopia and rural Jimma University, ...
... Cardiac Arrest,Association (SCAA) has appointed Chris Chiames as its ... join SCAA as we begin to implement our,strategic plan, ... goal of,eliminating preventable sudden cardiac arrest deaths (SCA) by ... Board of Directors.,"Advancements in medical technology and treatment can ...
... local nonprofit alcohol and,drug treatment agencies have formed ... the children of alcoholics and other drug addicts.,Recovery ... to produce a public awareness campaign, provide training ... is being,funded through a $145,000 grant from the ...
... Mice containing a mutated human gene implicated in autism ... the title characters traits in the movie Rain Man,? researchers ... study also shows how the mutation affects nerve function and ... the debilitating condition. , Its an attempt to replicate, as ...
... bigger toll than other chronic conditions , , FRIDAY, Sept. ... diseases, depression may well be the most disabling disease ... People with chronic physical diseases such as angina, arthritis, ... also suffer from depression, the team of international researchers ...
... Surface Offers Safe, ... Effective Alternative to Surgery, COLUMBUS, Ohio, Sept. ... world,s first physician on Wednesday, Aug.,29, to treat a common ... improves outcomes, speeds recovery and may minimize the risk of,complications. ...
Cached Medicine News:Health News:Tulane University to receive $14M for international HIV/AIDS program 2Health News:Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association 2Health News:Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program 2Health News:'Rain Man' mice provide model for autism 2Health News:Depression May Be World's Most Disabling Disease 2Health News:Depression May Be World's Most Disabling Disease 3Health News:Riverside First to Offer New Treatment for Peripheral Arterial Disease 2Health News:Riverside First to Offer New Treatment for Peripheral Arterial Disease 3
(Date:7/30/2015)...  Lannett Company, Inc. (NYSE: LCI ) today ... Genuity 35th Annual Growth Conference on Wednesday, August 12, ... Hotel.  A webcast of the presentation ... encouraged to visit the web site at least 10 ... register, download and install any necessary software.  The presentation ...
(Date:7/30/2015)... 30, 2015  Cleave Biosciences today announced that ... granted the company a key patent providing the ... CB-5083. This newly issued patent, "Fused ... U.S. 9,062,026, allows for claims on the composition ... oral inhibitor of p97, a critical enzyme that ...
(Date:7/30/2015)... , July 30, 2015 Flexpoint Ford, a ... services sectors, today announced that it has entered into ... Bryan Stuart to form Kastle Therapeutics, LLC (Kastle).  ... , will focus on acquiring, developing and commercializing pharmaceuticals ... acquisition opportunities include select therapies already approved for marketing, ...
Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
Disposable scalp clip applier, comes loaded with 12 Leroy-Raney clips, ergonomic, easy to handle and position the clip....
... Multifunctional instrumentation, capable of comminution, ... by means of ultra-sonic energy. ... organs, and, in particular, parenchymatous ... of tissue-selection and non-traumatic preparation ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 7.5 mm....
Medicine Products: